<VariationArchive RecordType="classified" VariationID="17822" VariationName="NM_000103.4(CYP19A1):c.469del (p.Val158fs)" VariationType="Deletion" Accession="VCV000017822" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-17" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32861" VariationID="17822">
      <GeneList>
        <Gene Symbol="CYP19A1" FullName="cytochrome P450 family 19 subfamily A member 1" GeneID="1588" HGNC_ID="HGNC:2594" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="51208057" stop="51338596" display_start="51208057" display_stop="51338596" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="51500253" stop="51630794" display_start="51500253" display_stop="51630794" Strand="-" />
          </Location>
          <OMIM>107910</OMIM>
        </Gene>
        <Gene Symbol="MIR4713HG" FullName="MIR4713 host gene" GeneID="109729174" HGNC_ID="HGNC:53124" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="51037488" stop="51293912" display_start="51037488" display_stop="51293912" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PIRC66" FullName="piwi-interacting RNA cluster 66" GeneID="100313865" HGNC_ID="HGNC:37570" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="51037584" stop="51322397" display_start="51037584" display_stop="51322397" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000103.4(CYP19A1):c.469del (p.Val158fs)</Name>
      <CanonicalSPDI>NC_000015.10:51222507:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="51222508" stop="51222508" display_start="51222508" display_stop="51222508" variantLength="1" positionVCF="51222507" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="51514705" stop="51514705" display_start="51514705" display_stop="51514705" variantLength="1" positionVCF="51514704" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V158fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031226.3" sequenceAccession="NM_031226" sequenceVersion="3" change="c.469del">
            <Expression>NM_031226.3:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_112503.1" sequenceAccession="NP_112503" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_112503.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.51222509del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.51222509del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.51514706del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.51514706del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007982.1" sequenceAccession="NG_007982" sequenceVersion="1" change="g.121091del">
            <Expression>NG_007982.1:g.121091del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000103.4" sequenceAccession="NM_000103" sequenceVersion="4" change="c.469del" MANESelect="true">
            <Expression>NM_000103.4:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000094.2" sequenceAccession="NP_000094" sequenceVersion="2" change="p.Val158fs">
            <Expression>NP_000094.2:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347248.1" sequenceAccession="NM_001347248" sequenceVersion="1" change="c.469del">
            <Expression>NM_001347248.1:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334177.1" sequenceAccession="NP_001334177" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334177.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347249.2" sequenceAccession="NM_001347249" sequenceVersion="2" change="c.469del">
            <Expression>NM_001347249.2:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334178.1" sequenceAccession="NP_001334178" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334178.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347250.2" sequenceAccession="NM_001347250" sequenceVersion="2" change="c.469del">
            <Expression>NM_001347250.2:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334179.1" sequenceAccession="NP_001334179" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334179.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347251.2" sequenceAccession="NM_001347251" sequenceVersion="2" change="c.469del">
            <Expression>NM_001347251.2:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334180.1" sequenceAccession="NP_001334180" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334180.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347252.2" sequenceAccession="NM_001347252" sequenceVersion="2" change="c.469del">
            <Expression>NM_001347252.2:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334181.1" sequenceAccession="NP_001334181" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334181.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347253.2" sequenceAccession="NM_001347253" sequenceVersion="2" change="c.469del">
            <Expression>NM_001347253.2:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334182.1" sequenceAccession="NP_001334182" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334182.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347254.2" sequenceAccession="NM_001347254" sequenceVersion="2" change="c.469del">
            <Expression>NM_001347254.2:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334183.1" sequenceAccession="NP_001334183" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334183.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347255.2" sequenceAccession="NM_001347255" sequenceVersion="2" change="c.469del">
            <Expression>NM_001347255.2:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334184.1" sequenceAccession="NP_001334184" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334184.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347256.2" sequenceAccession="NM_001347256" sequenceVersion="2" change="c.469del">
            <Expression>NM_001347256.2:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334185.1" sequenceAccession="NP_001334185" sequenceVersion="1" change="p.Val158fs">
            <Expression>NP_001334185.1:p.Val158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="107910.0008" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000103.4(CYP19A1):c.469del (p.Val158fs) AND Aromatase deficiency" Accession="RCV000019400" Version="27">
        <ClassifiedConditionList TraitSetID="5883">
          <ClassifiedCondition DB="MedGen" ID="C1960539">Aromatase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1999-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10566648</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5883" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12891" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aromatase deficiency</ElementValue>
                <XRef ID="MONDO:0013301" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Increased aromatase activity</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudohermaphroditism, female, due to placental aromatase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Aromatase deficiency is a rare autosomal recessive disorder in which individuals cannot synthesize endogenous estrogens. If a fetus lacks aromatase activity, dehydroepiandrosterone sulfate produced by the fetal adrenal glands cannot be converted to estrogen by the placenta, and is converted to testosterone peripherally and results in virilization of both fetus and mother. Virilization manifests as pseudohermaphroditism in female infants, with hirsutism and acne in the mother; the maternal indicators resolve following delivery. Affected females are usually diagnosed at birth because of the pseudohermaphroditism. Cystic ovaries and delayed bone maturation can occur during childhood and adolescence in these girls, who present at puberty with primary amenorrhea, failure of breast development, virilization, and hypergonadotropic hypogonadism. Affected males do not present with obvious defects at birth. Their clinical symptoms include tall stature, delayed skeletal maturation, delayed epiphyseal closure, bone pain, eunuchoid body proportions, and excess adiposity. Estrogen replacement therapy reverses the symptoms in males and females (summary by Jones et al., 2007).</Attribute>
                <XRef Type="MIM" ID="613546" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="365" />
                <XRef ID="365" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="91" DB="Orphanet" />
              <XRef ID="C1960539" DB="MedGen" />
              <XRef ID="MONDO:0013301" DB="MONDO" />
              <XRef Type="MIM" ID="613546" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39690" SubmissionDate="2013-01-30" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="107910.0008_AROMATASE DEFICIENCY" title="CYP19A1, 1-BP DEL, C, CODON 156_AROMATASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV000039690" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Deladoey et al. (1999) identified a point mutation in the CYP19 gene that was responsible for aromatase deficiency (613546) in a 46,XY male infant with unremarkable clinical findings at birth. The boy was homozygous for a 1-bp deletion (codon 156, C) in exon 5 of the CYP19 gene. Aromatase deficiency was suspected prenatally because of the severe virilization of the mother during the early pregnancy, and the diagnosis was confirmed shortly after birth. Four weeks after birth, the boy showed extremely low levels of serum estrogens but had a normal level of serum free testosterone; in comparison with the high serum concentration of androstenedione at birth, a striking decrease occurred by 4 weeks postnatally. The authors had previously reported elevated basal and stimulated FSH levels in a female infant with aromatase deficiency in the first year of life. In contrast, in the male infant, basal FSH and peak FSH levels after standard GnRH stimulation tests were normal. The authors concluded that the contribution of estrogen to the hypothalamic-pituitary gonadotropin-gonadal feedback mechanism is different in boys and girls during infancy and early childhood. They hypothesized that in normal girls serum estradiol concentrations strongly correlate with circulating inhibin levels, and thus, low inhibin levels may contribute to the striking elevation of FSH in young girls with aromatase deficiency. In contrast, estradiol levels are physiologically about 7-fold lower in boys than in girls, and serum inhibin levels remain elevated even though levels of FSH, LH, and testosterone are decreased.</Attribute>
              <Citation>
                <ID Source="PubMed">10566648</ID>
              </Citation>
              <XRef DB="OMIM" ID="613546" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP19A1" />
          </GeneList>
          <Name>CYP19A1, 1-BP DEL, C, CODON 156</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, C, CODON 156</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="107910.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AROMATASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39690" TraitType="Disease" MappingType="Name" MappingValue="AROMATASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C1960539" Name="Aromatase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

